학술논문
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
Document Type
Article
Author
Source
Subject
*ALZHEIMER'S patients
*PILOT projects
*IMMUNOTHERAPY
*
*
Language
ISSN
2047-9158
Abstract
Trial registration: ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153 [ABSTRACT FROM AUTHOR]